These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8001394)

  • 1. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
    Nelson D; Kuppermann N; Fleisher GR; Hammer BK; Thompson CM; Garcia CT; Novitsky TJ; Parsonnet J; Onderdonk A; Siber GR
    Crit Care Med; 1995 Jan; 23(1):92-8. PubMed ID: 8001394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.
    Weiner DL; Kuppermann N; Saladino RA; Thompson CM; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Sep; 24(9):1514-7. PubMed ID: 8797624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
    Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
    Kuppermann N; Nelson DS; Saladino RA; Thompson CM; Sattler F; Novitsky TJ; Fleisher GR; Siber GR
    J Infect Dis; 1994 Sep; 170(3):630-5. PubMed ID: 8077721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
    Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
    Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
    Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
    Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .
    Stack AM; Saladino RA; Siber GR; Thompson C; Marra MN; Novitsky TJ; Fleisher GR
    Crit Care Med; 1997 Jan; 25(1):101-5. PubMed ID: 8989184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
    Tsukada K; Katoh H; Shiojima M; Takenoshita S; Nagamachi Y
    APMIS; 1993 Feb; 101(2):97-100. PubMed ID: 8489768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
    Stack AM; Saladino RA; Thompson C; Sattler F; Weiner DL; Parsonnet J; Nariuchi H; Siber GR; Fleisher GR
    Crit Care Med; 1995 Sep; 23(9):1512-8. PubMed ID: 7664553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.
    Rogy MA; Moldawer LL; Oldenburg HS; Thompson WA; Montegut WJ; Stackpole SA; Kumar A; Palladino MA; Marra MN; Lowry SF
    Ann Surg; 1994 Jul; 220(1):77-85. PubMed ID: 8024362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.
    Porat R; Paddock HN; Schwaitzberg SD; Connolly RJ; Wilkens T; Dasch JR; Gascon MP; Hutchison JS; Ythier A; Wallach D
    Crit Care Med; 1995 Jun; 23(6):1080-9. PubMed ID: 7774220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.
    Shenep JL; Mogan KA
    J Infect Dis; 1984 Sep; 150(3):380-8. PubMed ID: 6384378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.
    Shenep JL; Barton RP; Mogan KA
    J Infect Dis; 1985 Jun; 151(6):1012-8. PubMed ID: 3889171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Silvestri C; Orlando F; Kamysz W; Licci A; Kamysz E; Lukasiak J; Saba V; Scalise G
    Crit Care Med; 2006 Sep; 34(9):2415-20. PubMed ID: 16791114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of different classes antimicrobial agents on plasma endotoxin activity.
    Nitsche D; Schulze C; Oesser S; Dalhoff A; Sack M
    Arch Surg; 1996 Feb; 131(2):192-9. PubMed ID: 8611078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant tumor necrosis factor-alpha p80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor-alpha but not lung injury or mortality during immunosuppression-related gram-negative bacteremia.
    Lechner AJ; Johanns CA; Matuschak GM
    J Crit Care; 1997 Mar; 12(1):28-38. PubMed ID: 9075062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibiotics on gram-negative sepsis in the rat. Lack of endotoxin burst.
    Almdahl SM; Osterud B
    Acta Chir Scand; 1987 Apr; 153(4):283-6. PubMed ID: 3307255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin-neutralizing protein.
    Ensley RJ; Browne WT
    Crit Care Med; 1995 May; 23(5):983. PubMed ID: 7736764
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.